WithdrawnNot Applicable

Evaluation of Dexterous Terminal Device

Stopped: Grant concluded.

0Started 2022-12-22

Plain-language summary

Liberating Technologies, Inc. (LTI) has developed Pointdexter, a dexterous prosthetic fingertip that is integrated into a commercial prosthetic hand and allows for an additional fine grasp. The Pointdexter device interfaces with upper limb prostheses by swapping the usual prosthetic pointer finger with the Pointdexter device. The dexterous prosthetic fingertip utilizes the same control strategy used to operate the prosthetic hand. This solution aims to combine the advantages of the common terminal devices into one product by combining the practicality and dexterity of a split-hook or gripper with the aesthetics of multi-articulating hands.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have an upper limb absence * Uses myoelectric control for their prosthesis * If they have a major upper limb absence, must use a quick-disconnect wrist * If able-bodied, must be willing to use an upper-limb prosthesis bypass for testing * Willing and able to complete activities outlined in the study and provide requested feedback. * Adults must be able to provide their own consent. Exclusion Criteria: * The risks to pregnant people and fetuses are unknown and therefore those who are pregnant should not participate in the study and will be screened by self-disclosure.

What they're measuring

Jebsen-Taylor Small Common Objects Functional Test

Timeframe: 4 hours

Trial details

NCT IDNCT05840601

SponsorLiberating Technologies, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-04-20

View on ClinicalTrials.gov More Amputation trials